Valneva falls as UK revokes marketing authorization for chikungunya vaccine

Regulatoryrejectedchikungunya vaccineNegative

AI Analysis

Summary

Valneva's chikungunya vaccine marketing authorization has been revoked by the UK regulatory authorities. This is a significant regulatory setback for the company's vaccine program.

Outcome Details

UK revoked marketing authorization

Importance:8/10

Sentiment:

-0.90

regulatorymarketing authorization revocationUKvaccine

Related Companies

$VLS

Read the original article

Published by Seeking Alpha Healthcare on October 7, 2026 9:41 PM

Read Original